118 related articles for article (PubMed ID: 36176053)
1. Safely omitting bone isotope scans in a cohort of grade group 2 prostate cancer.
Mustaffa A; Emara S
Prostate; 2023 Jan; 83(1):128-131. PubMed ID: 36176053
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Establishing the pathways and indications for performing isotope bone scans in newly diagnosed intermediate-risk localised prostate cancer - results from a large contemporaneous cohort.
KandaSwamy GV; Bennett A; Narahari K; Hughes O; Rees J; Kynaston H
BJU Int; 2017 Nov; 120(5B):E59-E63. PubMed ID: 28317247
[TBL] [Abstract][Full Text] [Related]
4. Broadening the criteria for avoiding staging bone scans in prostate cancer: a retrospective study of patients at the Royal Marsden Hospital.
O'Sullivan JM; Norman AR; Cook GJ; Fisher C; Dearnaley DP
BJU Int; 2003 Nov; 92(7):685-9. PubMed ID: 14616446
[TBL] [Abstract][Full Text] [Related]
5. The utilization of Gleason grade as the primary criterion for ordering nuclear bone scan in newly diagnosed prostate cancer patients.
Ritenour CW; Abbott JT; Goodman M; Alazraki N; Marshall FF; Issa MM
ScientificWorldJournal; 2009 Oct; 9():1040-5. PubMed ID: 19802499
[TBL] [Abstract][Full Text] [Related]
6. Changing the referral criteria for bone scan in newly diagnosed prostate cancer patients.
McArthur C; McLaughlin G; Meddings RN
Br J Radiol; 2012 Apr; 85(1012):390-4. PubMed ID: 21304009
[TBL] [Abstract][Full Text] [Related]
7. Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? A multicenter retrospective study in Japan.
Kosuda S; Yoshimura I; Aizawa T; Koizumi K; Akakura K; Kuyama J; Ichihara K; Yonese J; Koizumi M; Nakashima J; Fujii H
Cancer; 2002 Feb; 94(4):964-72. PubMed ID: 11920464
[TBL] [Abstract][Full Text] [Related]
8. Do all patients with newly diagnosed prostate cancer need staging radionuclide bone scan? A retrospective study.
Al-Ghazo MA; Ghalayini IF; Al-Azab RS; Bani-Hani I; Barham A; Haddad Y
Int Braz J Urol; 2010; 36(6):685-91; discussion 691-2. PubMed ID: 21176275
[TBL] [Abstract][Full Text] [Related]
9. Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer.
Gleave ME; Coupland D; Drachenberg D; Cohen L; Kwong S; Goldenberg SL; Sullivan LD
Urology; 1996 May; 47(5):708-12. PubMed ID: 8650870
[TBL] [Abstract][Full Text] [Related]
10. Which patients with newly diagnosed prostate cancer need a radionuclide bone scan? An analysis based on 631 patients.
Lee N; Fawaaz R; Olsson CA; Benson MC; Petrylak DP; Schiff PB; Bagiella E; Singh A; Ennis RD
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1443-6. PubMed ID: 11121646
[TBL] [Abstract][Full Text] [Related]
11. [The criteria for avoiding unnecessary computerized tomography and bone scan in staging patients with newly diagnosed prostate cancer: retrospective study of patients at Matsusaka Chuo General Hospital].
Matsumura Y; Otani T; Yoneda T; Matsumoto Y; Maruyama Y; Fujimoto K; Hirao Y
Nihon Hinyokika Gakkai Zasshi; 2007 Sep; 98(6):764-9. PubMed ID: 17929458
[TBL] [Abstract][Full Text] [Related]
12. Retrospective study of predictors of bone metastasis in prostate cancer cases.
Ho CC; Seong PK; Zainuddin ZM; Abdul Manaf MR; Parameswaran M; Razack AH
Asian Pac J Cancer Prev; 2013; 14(5):3289-92. PubMed ID: 23803117
[TBL] [Abstract][Full Text] [Related]
13. [Predictive value of prostate-specific antigen and Gleason sum for results of radionuclide bone scintigraphy in patients with prostate cancer].
Wang TY; Chen XP; Li XS; Jia Yx; Cheng J; Zhang JH; Cai L; Zhang Z; Gong K; He ZS; Zhou LQ
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 44(4):528-34. PubMed ID: 22898839
[TBL] [Abstract][Full Text] [Related]
14. A study on staging bone scans in newly diagnosed prostate cancer.
Ayyathurai R; Mahapatra R; Rajasundaram R; Srinivasan V; Archard NP; Toussi H
Urol Int; 2006; 76(3):209-12. PubMed ID: 16601380
[TBL] [Abstract][Full Text] [Related]
15. Serum prostate-specific antigen as a predictor of radiographic staging studies in newly diagnosed prostate cancer.
Huncharek M; Muscat J
Cancer Invest; 1995; 13(1):31-5. PubMed ID: 7530590
[TBL] [Abstract][Full Text] [Related]
16. A Bone Scan Is Valuable for Primary Staging of Newly Diagnosed Prostate Cancer in a Low-Resource Setting (Nigeria).
Orunmuyi AT; Adebayo SA; Ilesanmi OS; Takure AO; Olapade-Olaopa EO
Nucl Med Mol Imaging; 2022 Apr; 56(2):96-101. PubMed ID: 35464673
[TBL] [Abstract][Full Text] [Related]
17. Are serial bone scans useful for the follow-up of clinically localized, low to intermediate grade prostate cancer managed with watchful observation alone?
Yap BK; Choo R; Deboer G; Klotz L; Danjoux C; Morton G
BJU Int; 2003 May; 91(7):613-7. PubMed ID: 12699470
[TBL] [Abstract][Full Text] [Related]
18. Bone scan overuse in staging of prostate cancer: an analysis of a Veterans Affairs cohort.
Palvolgyi R; Daskivich TJ; Chamie K; Kwan L; Litwin MS
Urology; 2011 Jun; 77(6):1330-6. PubMed ID: 21492911
[TBL] [Abstract][Full Text] [Related]
19. Can prostate-specific antigen levels predict bone scan evidence of metastases in newly diagnosed prostate cancer?
Vijayakumar V; Vijayakumar S; Quadri SF; Blend MJ
Am J Clin Oncol; 1994 Oct; 17(5):432-6. PubMed ID: 7522394
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen, Gleason sum and clinical T stage for predicting the need for radionuclide bone scan for prostate cancer patients in Japan.
Ishizuka O; Tanabe T; Nakayama T; Kawakami M; Kinebuchi Y; Nishizawa O
Int J Urol; 2005 Aug; 12(8):728-32. PubMed ID: 16174046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
